[PDF][PDF] Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report
S Saleemi, B Alothman, F Albaiz… - Experimental and …, 2020 - researchgate.net
Lung toxicity is a rare but serious side effect of sirolimus, a mammalian target of rapamycin
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report.
S Saleemi, B Alothman, F Albaiz… - … : Official Journal of the …, 2020 - europepmc.org
Lung toxicity is a rare but serious side effect of sirolimus, a mammalian target of rapamycin
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
Role of fluorodeoxyglucose positron emission tomogram scan in sirolimus-induced lung toxicity: A rare case report
S Saleemi, B Alothman, F Albaiz… - Experimental and …, 2020 - ksascholar.dri.sa
Lung toxicity is a rare but serious side effect of sirolimus, a mammalian target of rapamycin
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report
S Saleemi, B Alothman, F Albaiz… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Lung toxicity is a rare but serious side effect of sirolimus, a mammalian target of rapamycin
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We …